Skip to Main Content
Book cover for Oxford Handbook of Palliative Care (2 edn) Oxford Handbook of Palliative Care (2 edn)
Max Watson et al.

A newer edition of this book is available.

Close

Contents

Book cover for Oxford Handbook of Palliative Care (2 edn) Oxford Handbook of Palliative Care (2 edn)
Max Watson et al.
Disclaimer
Oxford University Press makes no representation, express or implied, that the drug dosages in this book are correct. Readers must therefore always … More Oxford University Press makes no representation, express or implied, that the drug dosages in this book are correct. Readers must therefore always check the product information and clinical procedures with the most up to date published product information and data sheets provided by the manufacturers and the most recent codes of conduct and safety regulations. The authors and the publishers do not accept responsibility or legal liability for any errors in the text or for the misuse or misapplication of material in this work. Except where otherwise stated, drug dosages and recommendations are for the non-pregnant adult who is not breastfeeding.

Non-medical prescribing was first suggested in 1986 in the Cumberledge Report. It took 13 years for the vision to be realized and for nurse prescribing to be piloted in the community setting using a very limited formulary. Following a successful pilot, non-medical prescribing became a national initiative in 1998. Initially, it was aimed at health visitors and district nurses. Then in 2002 this was extended to enable nurses in other clinical areas, including palliative care, to train as non-medical prescribers using a limited formulary. In 2006 the decision was made to allow nurses, who had completed relevant training, to prescribe independently within their professional scope of practice, from the whole British National Formulary (with the exception of certain controlled drugs).

Evaluations of non-medical prescribing have been favourable, with patients and doctors being generally positive about the concept.1 The majority of nurse prescribers feel strongly that prescribing has had a positive impact on quality of patient care and improved access to medicines. Nurses have also reported that the training to be a non-medical prescriber has enhanced their knowledge about medication and increased their confidence to engage in prescribing decisions.2

With end of life care and choice of place of care being key principles of palliative care, nurse prescribing could play an important role in developing and meeting these challenges in the future. We repeatedly hear how there have been delays in gaining a prescription for a patient in the community, causing them to have to wait to commence new medication, or in the extreme case needing to be admitted to hospital. Non-medical prescribing is an option to be considered to assist in meeting these issues as community palliative care nurses will often advise GPs on medication options. Community palliative care nurses who have become non-medical prescribers suggest that patients receive medicines more quickly which they have interpreted as improving patient care.3

It is not only community palliative care nurses who should consider non-medical prescribing as part of their role. Hospital palliative care nurses and hospice nurses need to consider whether there is a place for non-medical prescribing within their role, asking the question would it improve the care I provide for patients?

BNF
(
2008
) Infections. In
British National Formulary
. London: BMJ Publishing Group Ltd and RPS Publishing.

Clinical
Resource Efficiency Support Team (
2005
) Guidelines on the Management of Cellulitis in Adults Beleast:. CREST Secretariat.

Eastern
Health and Social Services Board. (
2004
–2005)
Hospital Formulary
.

Twycross
R., Wilcock A. (
2007
)
Palliative Care Formulary
. (3rd edn) Nottingham: www.palliativedrugs.com.

Brabin
E. (
2008
) How effective are parenteral antibiotics in hospice patients. European Journal of Palliative Care  15(3): 115–125.

(

2001
). BTS guidelines for the management of community acquired pneumonia in adults.
Thorax
, 56(Suppl 4): IV1–64.

Clark
J. (
2002
) Metronidazole gel in managing malodorous fungating wounds.
British Journal of Nursing
, 11(6) (Suppl): 54–60.

Clayton
J., et al. (
2003
) Parenteral antibiotics in a palliative care unit: prospective analysis of current practice.
Palliative Medicine
, 17(1): 44–8.

Lam,
P. T. et al. (
2005
) Retrospective analysis of antibiotic use and survival in advanced cancer patients with infections. Journal of Pain and Symptom Management, 30(6): 536–43.

Macfarlane
J. T., Boldy D. (
2004
).
2004 update of BTS pneumonia guidelines: what’s new?
 
Thorax
, 59(5): 364–6.

Mirhosseini
M., et al. (
2006
) The role of antibiotics in the management of infection-related symptoms in advanced cancer patients.
Journal of Palliative Care
, 22(2): 69–74.

Moncino
M. D. a. J. M. F. (
1992
) Multiple relapses of Clostridium difficile-associated diarrhea in a cancer patient. Successful control with long-term cholestyramine therapy. American Journal of Pediatric Hematology and Oncology, 14(4): 361–4.

Mortimer
P. P. S. (
2007
) Consensus Document on the Management of Cellulitis in Lymphoedema: London: British Lymphology Society and the Lymphoedema Support Network.

Nagy-Agren
S. a. H. H. (
2002
) Management of infections in palliative care patients with advanced cancer. Journal of Pain and Symptom Management, 24(1): 64–70.

Oh
D. Y., et al. (
2006
). Antibiotic use during the last days of life in cancer patients. European Journal of Cancer Care, 15(1): 74–9.

Oneschuk
D., Fainsinger R., Demoissac D. (
2002
) Antibiotic use in the last week of life in three different palliative care settings
Journal of Palliative Care
, 18(1): 25–8.

Palace
G. P., Lazari P., et al. (
2001
) Analysis of the physicochemical interactions between Clostridium difficile toxins and cholestyramine using liquid chromatography with post-column derivatization.
Biochimica et Biophysica Acta
, 1546(1): 171–84.

Pereira
J., Watanabe S., Wolch G. (
1998
) A retrospective review of the frequency of infections and patterns of antibiotic utilization on a palliative care unit. Journal of Pain and Symptom Management, 16(6): 374–81.

Spruyt
O., Kausae A. (
1998
) Antibiotic use for infective terminal respiratory secretions. Journal of Pain and Symptom Management, 15(5): 263–4.

Stroehlein
J. R. (
2004
) Treatment of Clostridium difficile infection. Current Treatment Options in Gastroenterology, 7(3): 235–9.

Venkatesan
P., et al. (
1990
) A hospital study of community acquired pneumonia in the elderly.
Thorax
, 45(4): 254–8.

Vitetta
L., Kenner D., Sali A. (
2000
) Bacterial infections in terminally ill hospice patients. Journal of Pain and Symptom Management, 20(5): 326–34.

White
P. H., et al. (
2003
) Antimicrobial use in patients with advanced cancer receiving hospice care. Journal of Pain and Symptom Management  25(5): 438–43.

Notes
1

Latter S., et al. (2005) An Evaluation of Extended Formulary Independent Nurse Prescribing: Final Report. London: Department of Health.

2

Bradley E., Nolan P. (2007) Impact of nurse prescribing: a qualitative study. Journal of Advanced Nursing, 59(2): 120–8.reference

3

Ryan-Woolley B., McHugh G., Luker K, (2007) Prescribing by specialist nurses in cancer and palliative care: results of a national survey. Palliative Medicine, 21: 273–7.reference

Close
This Feature Is Available To Subscribers Only

Sign In or Create an Account

Close

This PDF is available to Subscribers Only

View Article Abstract & Purchase Options

For full access to this pdf, sign in to an existing account, or purchase an annual subscription.

Close